⌕
Olema Oncology · OLMA · Nasdaq
Tenet 55 · Mixed
Compare
$7.36−2.65%At closeTenet 55 · Mixed
$7.36−0.20 (−2.65%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Olema Oncology (OLMA) Institutional Ownership

13F filers reported holding 59.9% of Olema Oncology (OLMA) shares as of Sep 30, 2026, across 143 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
59.9%
Sep 30, 2026
13F filers
143
quarter ended Sep 30, 2026
13F value
$453.4M
52.5M shares
Quarter's fund flow
Mild accumulation
22 new · 17 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (22 new · 54 increased · 27 reduced · 17 closed · 23 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 48 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 143 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 48 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 1, 2026O'Byrne JasonCHIEF FINANCIAL OFFICERAcquired · Grant / award650,000Stock Option (Right to Buy)—↗
Jul 24, 2026Harmon CyrusdirectorDisposed · Open-market sale12,500$11.71↗
Jul 23, 2026Harmon CyrusdirectorDisposed · Open-market sale12,500$11.58↗
Jun 18, 2026BVF PARTNERS L P/ILdirectorAcquired · Grant / award29,500Stock Option (Right to buy)—↗
Jun 18, 2026Harmon CyrusdirectorAcquired · Grant / award29,500Stock Option (Right to Buy)—↗
Jun 18, 2026BUTITTA CYNTHIA MdirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026Garland J. ScottdirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026Hrustanovic GorjandirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026CLARK IAN TdirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026Larson YidirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026Horning SandradirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026Raman PrakashdirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026RAPPAPORT ANDREWdirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Jun 18, 2026Graham G. WalmsleydirectorAcquired · Grant / award29,500Stock Option (right to buy)—↗
Apr 28, 2026Raman PrakashdirectorAcquired · Grant / award2,911Stock Option (Right to Buy)—↗
Apr 28, 2026Raman PrakashdirectorAcquired · Grant / award24,150Stock Option (Right to Buy)—↗
Mar 4, 2026Mitchell ShawnteCHIEF LEGAL OFFICERAcquired · Option exercise25,000$4.37↗
Mar 4, 2026Mitchell ShawnteCHIEF LEGAL OFFICERDisposed · Open-market sale24,767$24.25↗
Mar 4, 2026Mitchell ShawnteCHIEF LEGAL OFFICERDisposed · Open-market sale233Comon Stock$24.69↗
Mar 4, 2026Mitchell ShawnteCHIEF LEGAL OFFICERDisposed · Option exercise25,000Stock Option (Right to Buy)—↗

* Holdings as reported for Sep 30, 2026, 48 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Olema Oncology do institutions hold?

13F filers reported holding 59.9% of Olema Oncology's shares as of Sep 30, 2026, across 143 filers.

How many 13F filers hold Olema Oncology?

Olema Oncology was held by 143 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.